The Global light therapy market was valued at US$ 1.0 Billion in 2022, and is projected to reach US$ 1.37 Billion by 2030, growing at a CAGR of 4.6% from 2023 to 2030.

The global light therapy market refers to the market for devices and services that use light to treat various medical conditions, including skin disorders, sleep disorders, and seasonal affective disorder (SAD). The increasing prevalence of skin disorders, sleep disorders, and SAD, coupled with the growing demand for non-invasive treatment options, is driving the growth of the light therapy market. Additionally, the growing awareness about the benefits of light therapy and the increasing adoption of light therapy devices by healthcare professionals and patients are also contributing to market growth.

The light therapy market can be segmented based on the product type, application, end-user, and geography. Based on product type, the market can be segmented into light boxes, lamps, dawn simulators, light visors, handheld devices, and others. Based on application, the market can be segmented into skin disorders, sleep disorders, SAD, neonatal jaundice, and others. Based on end-user, the market can be segmented into hospitals, homecare settings, and others.

Geographically, the light therapy market can be segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate the market due to the high prevalence of skin disorders, sleep disorders, and SAD in the region, coupled with the high adoption of light therapy devices by healthcare professionals and patients.

The key players in the light therapy market include Koninklijke Philips N.V., Northern Light Technology, Beurer GmbH, Lumie, Verilux, Inc., Chal-Tec GmbH, Aura Daylight, Photomedex, Inc., Red Light Rising, and Sphere Gadget Technologies. The market is highly competitive, with players competing based on product innovation, pricing, and distribution channels.

The light therapy market is expected to experience significant growth in the coming years, driven by the increasing prevalence of medical conditions that can be treated with light therapy and the growing demand for non-invasive treatment options. Additionally, the increasing adoption of light therapy devices by healthcare professionals and patients is also expected to contribute to market growth.

Market Dynamics

Driving Factors

There are several driving factors behind the growth of the global light therapy market. These include:

Increased Adoption by Healthcare Professionals: Light therapy is becoming an increasingly popular treatment option among healthcare professionals, who are recommending it to their patients. This is driving the demand for light therapy devices in hospitals and other healthcare settings.

Aging Population: The aging population is also contributing to the growth of the light therapy market. Older individuals are more likely to suffer from medical conditions such as skin disorders, sleep disorders, and SAD, and are therefore more likely to use light therapy devices.

Restraining Factors

There are several driving factors behind the growth of the global light therapy market, there are also several factors that may restrain the market's growth. These include:

Limited Insurance Coverage: While some insurance plans may cover the cost of light therapy devices, many plans do not cover this treatment option. This may limit the adoption of light therapy devices by patients who cannot afford to pay for them out of pocket.

Availability of Alternative Treatment Options: While light therapy is a non-invasive treatment option, there are alternative treatment options available for many medical conditions. For example, medications and surgery may be more effective for some conditions, which may limit the adoption of light therapy devices and services.

Challenges Factors

there are several opportunities for growth in the global light therapy market, there are also several challenges that must be addressed. These include:

Safety Concerns: While light therapy is generally safe, there are some safety concerns associated with its use, particularly with prolonged or excessive exposure to light. Manufacturers need to address these safety concerns and develop safe and effective devices that can be used without risk of harm.

Limited Clinical Evidence: There is limited clinical evidence to support the use of light therapy for certain conditions. Manufacturers need to continue to invest in research to generate clinical evidence and demonstrate the effectiveness of light therapy for different medical conditions.

Opportunity Factors

Despite the restraining factors, there are still several opportunities for growth in the global light therapy market. These include:

Increasing Demand for Home-Based Light Therapy Devices: With the COVID-19 pandemic, there has been a growing trend towards home-based healthcare solutions. This has resulted in an increased demand for home-based light therapy devices that can be used by patients in the comfort of their own homes. As a result, there is an opportunity for manufacturers to develop and market more portable, convenient, and user-friendly devices for home use.

Rising Prevalence of Seasonal Affective Disorder (SAD): The rising prevalence of SAD presents an opportunity for light therapy manufacturers to develop and market devices specifically for this condition. SAD affects millions of people worldwide, and light therapy has been shown to be an effective treatment option.

Increasing Adoption by Dermatologists: Dermatologists are increasingly using light therapy to treat a variety of skin conditions, including acne, psoriasis, and eczema. This presents an opportunity for light therapy manufacturers to develop and market devices specifically for dermatologists.

Expansion into Emerging Markets: There is an opportunity for light therapy manufacturers to expand into emerging markets where there is limited awareness and access to light therapy devices. As the awareness about light therapy grows in these markets, there is potential for significant growth.

Segmentation Analysis

Product Outlook

Light boxes are large, rectangular light therapy devices that emit bright light. These devices are commonly used for the treatment of SAD, depression, and other mood disorders.

Light therapy bulbs are light therapy devices that can be used in any standard light fixture. These bulbs emit bright light and are commonly used for the treatment of SAD, depression, and other mood disorders. Light therapy masks are wearable light therapy devices that cover the face. These devices emit light directly onto the skin and are often used for the treatment of skin conditions such as acne and psoriasis.

End Use Outlook

Light therapy devices are commonly used in homes for the treatment of SAD, depression, and other mood disorders. Home-use light therapy devices are often smaller and more affordable than professional-grade devices, and can be used conveniently at home.

Light therapy devices are also used in sports and fitness settings to promote recovery and enhance performance. These devices are often used to treat muscle soreness, joint pain, and other injuries, and can help athletes recover more quickly and perform at their best. Light therapy devices are also used in beauty and wellness settings to promote healthy skin and hair. These devices are often used to treat acne, wrinkles, and other skin conditions, as well as to promote hair growth and prevent hair loss.

Regional Analysis

North America is expected to be the largest market for light therapy due to the high prevalence of seasonal affective disorder (SAD) and other mood disorders. The growing adoption of light therapy by dermatologists and professional athletes is also expected to drive market growth in this region.

The Middle East & Africa is expected to have a moderate growth rate due to the limited awareness and adoption of light therapy in this region. However, the growing healthcare infrastructure and rising prevalence of skin disorders in some countries may present opportunities for growth.

Latin America is expected to have a slow growth rate due to the limited awareness and adoption of light therapy in this region. However, the rising prevalence of mood disorders and skin disorders may present opportunities for growth in the future.

The regional analysis indicates that the demand for light therapy devices varies significantly depending on the region, and manufacturers need to develop region-specific strategies to drive market growth. While North America and Europe are expected to be the largest markets, the Asia-Pacific region presents significant opportunities for growth due to the increasing awareness and adoption of light therapy in this region.

Scope Of Report:

The Global Light Therapy Market has been segmented into:

By Product

• Light Box
• Floor and Desk Lamps
• Handheld Devices for Skin Treatment
• Light Visor
• Dawn Simulator
• Light Therapy Lamps

By Application

• Psoriasis
• Vitiligo
• Eczema
• Acne Vulgaris
• SAD/Winter Blues
• Sleeping Disorders

By Light Type

• Blue Light
• Red Light
• White Light

By End-use

• Dermatology Clinics
• Home Healthcare

By Region

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
  • Germany
  • France
  • Italy
  • Spain
  • UK
  • Nordic Countries
    • Denmark
    • Finland
    • Iceland
    • Sweden
    • Norway
  • Benelux Union
    • Belgium
    • The Netherlands
    • Luxembourg
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Southeast Asia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Rest of Southeast Asia
• Rest of Asia-Pacific
• The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

Market Players 

The global light therapy market is highly competitive and fragmented, with numerous players vying for market share. Some of the key companies in the market are:

• Koninklijke Philips N.V.
• Beurer GmbH
• BioPhotas.
• Northern Light Technologies
• Lumie
• Verilux, Inc
• Zepter International
• The Daylight Company
• Zerigo Health
• Naturebright

Koninklijke Philips N.V. is a Dutch multinational conglomerate that produces a range of healthcare products, including light therapy devices for the treatment of mood disorders, skin disorders, and other medical conditions. Beurer GmbH is a German company that produces a range of healthcare and wellness products, including light therapy devices for the treatment of mood disorders, skin disorders, and other medical conditions.

Verilux, Inc. is a US-based company that produces a range of light therapy devices for the treatment of mood disorders, sleep disorders, and other medical conditions. Northern Light Technologies is a Canadian company that produces light therapy devices for the treatment of mood disorders, sleep disorders, and other medical conditions.

Lumie is a UK-based company that produces a range of light therapy devices for the treatment of mood disorders, sleep disorders, and other medical conditions. Nature Bright is a US-based company that produces light therapy devices for the treatment of mood disorders, sleep disorders, and other medical conditions.

Carex Health Brands is a US-based company that produces a range of healthcare products, including light therapy devices for the treatment of mood disorders, sleep disorders, and other medical conditions. Red Light Man Ltd is a UK-based company that produces light therapy devices for the treatment of skin disorders and other medical conditions.

Strategic Developments

In January 2021, Lumie, a UK-based light therapy device manufacturer, was acquired by Verilux, Inc., a US-based light therapy device manufacturer. This acquisition is expected to help Verilux expand its presence in the European market and strengthen its product portfolio.

In December 2020, Philips launched a new light therapy device, the Philips SmartSleep Deep Sleep Headband. This device uses light therapy to help improve the quality of deep sleep and has received positive reviews from customers and healthcare professionals.

In August 2020, Northern Light Technologies, a Canadian light therapy device manufacturer, announced a partnership with the Canadian Mental Health Association to provide free light therapy devices to individuals with mood disorders.

In May 2020, Beurer GmbH, a German light therapy device manufacturer, announced the launch of its new Daylight Lamp TL100. This device is designed to simulate natural sunlight and help alleviate symptoms of SAD.

In April 2020, Nature Bright, a US-based light therapy device manufacturer, announced a partnership with WeWork to provide light therapy devices to WeWork's members. This partnership is expected to help Nature Bright expand its customer base and reach new customers in the US and internationally.

In February 2020, BioPhotas, a US-based light therapy device manufacturer, announced a partnership with a Canadian company, HealthMed Distributors. This partnership is expected to help BioPhotas expand its distribution network and reach new customers in Canada.